During the past decade, Rheumatology Center of San Diego conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Rheumatology Center of San Diego" #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "R-Pharm International, LLC" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Rheumatology Center of San Diego" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "IQVIA Pvt. Ltd" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Rheumatology Center of San Diego" are "Rheumatoid Arthritis" (3 trials), "Arthritis, Psoriatic" (2 trials), "Ankylosing Spondylitis" (1 trials), "Axial Spondyloarthritis" (1 trials) and "Spondyloarthritis" (1 trials). Many other conditions were trialed in "Rheumatology Center of San Diego" in a lesser frequency.

Most popular intervention types in "Rheumatology Center of San Diego" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Ixekizumab" (2 trials), "Adalimumab 40mg q2w" (1 trials), "Afimetoran" (1 trials) and "Apremilast (CC-10004)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Rheumatology Center of San Diego" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Rheumatology Center of San Diego". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Rheumatology Center of San Diego, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Rheumatology Center of San Diego, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".